Serotonin biosynthetic pathway enzyme(s) in enterochromaffin cell (None established; commonly referenced as "EC cell serotonin biosynthesis" or "TPH1-mediated serotonin synthesis")

Serotonin biosynthesis in enterochromaffin cells represents the principal source of peripheral serotonin in mammals, with EC cells synthesizing about 90–95% of total body serotonin through a pathway in which **tryptophan hydroxylase 1 (TPH1)** is the rate-limiting enzyme[1][3][8]. These cells are located in the GI mucosa, and act as mechanosensors and chemosensors, responding to diverse stimuli (nutrients, mechanical forces, microbial metabolites) via various sensory receptors (Piezo2, TRPA1, GPCRs)[4][5][6][8]. Upon activation, EC cells release serotonin, which modulates gut motility, fluid secretion, neuronal signaling, and communicates with both the enteric and central nervous systems[1][2][5][6][8]. Dysregulation of this serotonin biosynthetic pathway is strongly linked to gut dysfunctions (e.g., IBS, IBD), and increasingly recognized as a pharmacological target for GI and systemic diseases[5]. However, the term "serotonin biosynthesis in enterochromaffin cells" is not the canonical name of a molecule but of a biochemical process; the primary molecular target here is **Tryptophan hydroxylase 1 (TPH1)**[1][8].

Other names

EC cell serotonin synthesisEnterochromaffin cell serotonin productionPeripheral serotonin synthesisTPH1-mediated serotonin biosynthesis

Inhibiting TPH1 directly decreases serotonin production in EC cells[1][5][8]. Blocking serotonin receptors (e.g., 5-HT3 antagonists) reduces serotonin-mediated GI motility and sensation[4]. Modulating serotonin reuptake or release impacts downstream signaling in ENS and CNS[2][5].